In situ-forming PLGA implants loaded with leuprolide acetate/β-cyclodextrin complexes: mathematical modelling and degradation

References

• Agarwal P, Rupenthal ID. Injectable implants for the sustained release of protein and peptide drugs. Drug Discov Today, 2013;18:337–49.
   PubMed Web of Science ®Google Scholar
• Arifin DY, Lee LY, Wang CH. Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Adv Drug Deliv Rev, 2006;58:1274–325.
   PubMed Web of Science ®Google Scholar
• Barakat NS, Elbagory IM, Almurshedi AS. Controlled-release carbamazepine granules and tablets comprising lipophilic and hydrophilic matrix components. AAPS PharmSciTech, 2008;9:1054–62.
   PubMed Web of Science ®Google Scholar
• Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev, 2007;59:645–66.
   PubMed Web of Science ®Google Scholar
• Brodbeck KJ, Desnoyer JR, Mchugh AJ. Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. J Control Release, 1999;62:333–44.
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int J Pharm, 2008;346:151–9.
   PubMed Web of Science ®Google Scholar
• Casadesus G, Zhu X, Atwood CS, Webber KM, Perry G, Bowen RL, Smith MA. Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer’s disease. Curr Drug Targets: CNS Neurol Disorders, 2004;3:281–5.
   PubMedGoogle Scholar
• Correia I, Bezzenine N, Ronzani N, Platzer N, Beloeil JC, Doan BT. Study of inclusion complexes of acridine with β-and (2,6-di-Omethyl)-β-cyclodextrin by use of solubility diagrams and NMR spectroscopy. J Phys Org Chem, 2002;15:647–59.
   Web of Science ®Google Scholar
• Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharm, 2010;67:217–23.
   PubMed Web of Science ®Google Scholar
• Farahani TD, Entezami AA, Mobedi H, Abtahi M. Degradation of poly(d,l-lactide-co-glycolide) 50: 50 implant in aqueous medium. Iran Polym J, 2005;14:753–63.
   Web of Science ®Google Scholar
• Fu AS, Thatiparti TR, Saidel GM, Vonrecum HA. Experimental studies and modeling of drug release from a tunable affinity-based drug delivery platform. Ann Biomed Eng, 2011;39:2466–75.
   PubMed Web of Science ®Google Scholar
• Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. J Pharm Sci, 1967;56:1238–42.
   PubMed Web of Science ®Google Scholar
• Gil EC, Colarte AI, Bataille B, Caraballo I. Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets. AAPS PharmSciTech, 2007;8:E1–8.
   PubMed Web of Science ®Google Scholar
• Grassi M, Grassi G. Mathematical modelling and controlled drug delivery: Matrix systems. Curr Drug Deliv, 2005;2:97–116.
   PubMedGoogle Scholar
• Hak SC, Tooru O, Shintrao S, Nobuhiko Y. Control of rapid phase transition induced by supramolecular complexation of β-cyclodextrin-conjugated poly(ɛ-lysine) with a specific guest. Macromolecules, 2003;36:5342–7.
   Web of Science ®Google Scholar
• Hakkarainen M, Albetsson AC, Karlsson S. Weight losses and molecular weight changes correlated with the evolution of hydroxy-acids in simulated in vivo degradation of homo- and copolymers of PLA and PGA. Polym Degrad Stab, 1996;52:283–91.
   Web of Science ®Google Scholar
• Hall SC, Tan MM, Leonard JJ, Stevenson CL. Characterization and comparison of leuprolide degradation profiles in water and dimethyl sulfoxide. J Peptide Res, 1999;53:432–41.
   PubMedGoogle Scholar
• Hosmer JM, Shin SH, Nornoo A, Zheng H, Lopes LB. Influence of internal structure and composition of liquid crystalline phases on topical delivery of Paclitaxel. J Pharm Sci, 2011;100:1444–55.
   PubMed Web of Science ®Google Scholar
• Johansen P, Men Y, Audran R, Corradin G, Merkle HP, Gander B. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm Res, 1998;15:1103–10.
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y, Nishiyama T, Okada M, Kamachi M, Harada A. Complex formation of poly(ɛ-caprolactone) with cyclodextrins. Macromolecules, 2000;33:4472–7.
   Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 1983;15:25–35.
   Web of Science ®Google Scholar
• Korsmeyer RW, Peppas NA. Solute and penetrant diffusion in swellable polymers. III. Drug release from glassy poly (HEMA-co-NVP) copolymers. J Control Release, 1984;1:89–98.
   Google Scholar
• Lahiani-Skiba M, Boulet Y, Youm Ii, Bounoure F, Vérité P, Arnaud P, Skiba M. Interaction between hydrophilic drug and α-cyclodextrins: Physico-chemical aspects. J Incl Phenom Macrocycl Chem, 2007;57:211–17.
   Web of Science ®Google Scholar
• Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol, 1972;24:979–81.
   PubMed Web of Science ®Google Scholar
• Levy G, Hollister LE. Inter- and intrasubject variations in drug absorption kinetics. J Pharm Sci, 1964;53:1446–52.
   PubMed Web of Science ®Google Scholar
• Levy G, Leonards JR, Procknal JA. Development of in vitro dissolution tests which correlate quantitatively with dissolution rate-limited drug absorption in man. J Pharm Sci, 1965;54:1719–22.
   Web of Science ®Google Scholar
• Meethal SV, Smith MA, Bowen RI, Atwood CS. The gonadotropin connection in Alzheimer’s disease. Endocrine, 2005;26:317–26.
   PubMed Web of Science ®Google Scholar
• Miller JD, Anderson MG. Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata. Adv Drug Deliv Rev, 1997;28:139–55.
   PubMed Web of Science ®Google Scholar
• Miranda A, Millan M, Caraballo I. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery. Int J Pharm, 2006;311:75–81.
   PubMed Web of Science ®Google Scholar
• Parent M, Nouvel C, Koerber M, Sapin A, Maincent P, Boudier A. PLGA in situ implants formed by phase inversion: Critical physicochemical parameters to modulate drug release. J Control Release, 2013;172:292–304.
   PubMed Web of Science ®Google Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helvetiae, 1985;60:110–11.
   PubMedGoogle Scholar
• Peppas NA, Shalin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm, 1989;57:169–72.
   Web of Science ®Google Scholar
• Perez-Marrero R, Tyler RC. A subcutaneous delivery system for the extended release of leuprolide acetate for the treatment of prostate cancer. Expert Opin Pharmacother, 2004;5:447–57.
   PubMed Web of Science ®Google Scholar
• Pillay V, Fassihi R. In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. I. Comparison of pH-responsive drug release and associated kinetics. J Control Release, 1999;59:229–42.
   PubMed Web of Science ®Google Scholar
• Plosker GL, Brogden RN. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders. Drugs, 1994;48:930–67.
   PubMed Web of Science ®Google Scholar
• Polli JE, Rekhi GS, Augsburger LL, Shah VP. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci, 1997;86:690–700.
   PubMed Web of Science ®Google Scholar
• Rahimi M, Mobedi H, Behnamghader A. Aqueous stability of leuprolide acetate: Effect of temperature, dissolved oxygen, pH and complexation with β-cyclodextrin. Pharm Dev Technol, 2016a;21:108–15.
   PubMed Web of Science ®Google Scholar
• Rahimi M, Mobedi H, Behnamghader A. In situ forming poly(lactic acid-co-glycolic acid) implants containing leuprolide acetate/β-cyclodextrin complexes: Preparation, characterization and in vitro drug release. Int J Polym Mater Polym Biomater, 2016b;65:75–84.
   Web of Science ®Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release, 1987a;5:23–36.
   Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release. II. Fickian and Anomalous release from swellable devices. J Control Release, 1987b;5:37–42.
   Google Scholar
• Sathe PM, Tsong Y, Shah VP. In-vitro dissolution profile comparison: Statistics and analysis, model dependent approach. Pharm Res, 1996;13:1799–803.
   PubMed Web of Science ®Google Scholar
• Sharifi LDK. Leuprolide acetate (30-mg depot every four months) in the treatment of advanced prostate cancer. Urology, 1998;51:271–6.
   PubMed Web of Science ®Google Scholar
• Siepmann F, Siepmann J. Modeling of diffusion controlled drug delivery. J Control Release, 2012;161:351–62.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Elkharraz K, Siepmann F, Klose D. How autocatalysis accelerates drug release from PLGA-based microparticles?: A quantitative treatment. Biomacromolecules, 2005;6:2312–19.
   PubMed Web of Science ®Google Scholar
• Teutonico D, Montanari S, Ponchel G. Leuprolide acetate: Pharmaceutical use and delivery potentials. Expert Opin Drug Deliv, 2012;9:343–54.
   PubMed Web of Science ®Google Scholar
• Tsong Y, Hammerstrom T, Chen JJ. Multipoint dissolution specification and acceptance sampling rule based on profile modeling and principal component analysis. J Biopharm Stat, 1997;7:423–39.
   PubMedGoogle Scholar
• Walter E, Dreher D, Kok M, Thiele L, Kiama SG, Gehr P, Merkle HP. Hydrophilic poly(d,l-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. J Control Release, 2001;76:149–68.
   PubMed Web of Science ®Google Scholar
• Wang F, Saidel GM, Gao J. A mechanistic model of controlled drug release from polymer millirods: Effects of excipients and complex binding. J Control Release, 2007;119:111–20.
   PubMed Web of Science ®Google Scholar
• Yuksel N, Kanik AE, Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and-independent methods. Int J Pharm, 2000;209:57–67.
   PubMed Web of Science ®Google Scholar